The Business Of Biotech “Summer Executive Sessions” kick off with a candid conversation with Athersys CFO Ivor Macleod, who brings years of finance leadership at Roche, Merck, and other big pharmas to Athersys as the company readies its lead candidate for life beyond clinical trials. Join us for a discussion on how Macleod is applying […]

China, a global hotspot for liver and digestive system diseases, has emerged as an attractive target market for developers of genomic liver and colon cancer screening tests, with the potential to generate billions of dollars of annual revenue. California-based Helio – formerly the Laboratory for Advanced Medicine – will soon apply for approval in China […]

A cancer-fighting concept from the inventor of the first cancer vaccine is nearing prime time, and its biotech developer has received a significant new infusion of cash to get it there. Bolt Biotherapeutics announced a $93.5 million Series C round led by Sofinnova Investments and joined by more than 9 others, including Pfizer Ventures and […]